Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Parkinson's Disease

Free Subscription 19.12.2011 2 Arch Neurol 1 BMC Neurol 1 Brain Res 1 Exp Neurol 5 J Biol Chem 1 J Clin Pharmacol 1 J Neural Transm 1 J Neurol Neurosurg Psychiatry 4 J Neurosci 2 Lancet Neurol 15 Mov Disord 2 Neurosci Lett 1 Neuroscience

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Arch Neurol

1. DELUCA GC , Li G, Ramagopalan S
   Parkinson disease and vitamin d: an interplay between genes and the environment?
   Arch Neurol. 2011;68:1615-6.
   PubMed     Text format     Related articles   
   
   
   
2. WEINTRAUB D , Doshi J, Koka D, Davatzikos C, et al
   Neurodegeneration across stages of cognitive decline in Parkinson disease.
   Arch Neurol. 2011;68:1562-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   BMC Neurol

3. ENCIU AM , Nicolescu MI, Manole CG, Muresanu DF, et al
   Neuroregeneration in neurodegenerative disorders.
   BMC Neurol. 2011;11:75.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Brain Res

4. BELLUCCI A , Navarria L, Zaltieri M, Missale C, et al
   Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease.
   Brain Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Exp Neurol

5. DOMENGER D , Dea D, Theroux L, Moquin L, et al
   The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain.
   Exp Neurol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   J Biol Chem

6. LE HT , Gautier V, Kthiri F, Malki A, et al
   YajL, the prokaryotic homolog of the Parkinsonism associated protein DJ-1 functions as a covalent chaperone for the thiol proteome.
   J Biol Chem. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. REN H , Fu K, Wang D, Mu C, et al
   Oxidized DJ-1 interacts with the mitochondrial protein BCL-XL.
   J Biol Chem. 2011;286:35308-17.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. PEMBERTON S , Madiona K, Pieri L, Kabani M, et al
   Hsc70 protein interaction with soluble and fibrillar alpha-synuclein.
   J Biol Chem. 2011;286:34690-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. OLAH J , Vincze O, Virok D, Simon D, et al
   Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.
   J Biol Chem. 2011;286:34088-100.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. LAMBERTO GR , Torres-Monserrat V, Bertoncini CW, Salvatella X, et al
    Toward the discovery of effective polycyclic inhibitors of alpha-synuclein amyloid assembly.
    J Biol Chem. 2011;286:32036-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Clin Pharmacol

11. KNEBEL W , Rao N, Uchimura T, Mori A, et al
    Population Pharmacokinetic-Pharmacodynamic Analysis of Istradefylline in Patients With Parkinson Disease.
    J Clin Pharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Neural Transm

12. DI BIASIO F , Vanacore N, Fasano A, Modugno N, et al
    Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson's disease-dementia: which matters most?
    J Neural Transm. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Neurol Neurosurg Psychiatry

13. WILCOX RA , Cole MH, Wong D, Coyne T, et al
    Pedunculopontine nucleus deep brain stimulation produces sustained improvement in primary progressive freezing of gait.
    J Neurol Neurosurg Psychiatry. 2011;82:1256-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Neurosci

14. OLIVIERI S , Conti A, Iannaccone S, Cannistraci CV, et al
    Ceruloplasmin Oxidation, a Feature of Parkinson's Disease CSF, Inhibits Ferroxidase Activity and Promotes Cellular Iron Retention.
    J Neurosci. 2011;31:18568-18577.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. TORRES EB , Heilman KM, Poizner H
    Impaired endogenously evoked automated reaching in Parkinson's disease.
    J Neurosci. 2011;31:17848-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. ISAIAS IU , Moisello C, Marotta G, Schiavella M, et al
    Dopaminergic striatal innervation predicts interlimb transfer of a visuomotor skill.
    J Neurosci. 2011;31:14458-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. FOERDE K , Shohamy D
    Feedback timing modulates brain systems for learning in humans.
    J Neurosci. 2011;31:13157-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Lancet Neurol

18. ANTONINI A
    Movement disorders: towards new therapies in Parkinson's disease.
    Lancet Neurol. 2012;11:7-8.
    PubMed     Text format     Related articles   
    
    
    
19. VEKRELLIS K , Xilouri M, Emmanouilidou E, Rideout HJ, et al
    Pathological roles of alpha-synuclein in neurological disorders.
    Lancet Neurol. 2011;10:1015-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Mov Disord

20. VAN DER HOORN A , Hof AL, Leenders KL, de Jong BM, et al
    Narrowing wide-field optic flow affects treadmill gait in left-sided Parkinson's disease.
    Mov Disord. 2011 Dec 15. doi: 10.1002/mds.24011.
    PubMed     Text format     Related articles   
    
    
    
21. SETO-SALVIA N , Pagonabarraga J, Houlden H, Pascual-Sedano B, et al
    Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course.
    Mov Disord. 2011 Dec 15. doi: 10.1002/mds.24045.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. CUBO E , Trejo Gabriel-Galan JM, Seco Martinez J, Rioja Alcubilla C, et al
    Comparison of office-based versus home web-based clinical assessments for Parkinson's disease.
    Mov Disord. 2011 Dec 15. doi: 10.1002/mds.24028.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. FASANO A , Matteo AD, Vitale C, Squintani G, et al
    Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy.
    Mov Disord. 2011;26:2578-80.
    PubMed     Text format     Related articles   
    
    
    
24. DANIELS C , Krack P, Volkmann J, Raethjen J, et al
    Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
    Mov Disord. 2011;26:2516-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. BARONE P , Aarsland D, Burn D, Emre M, et al
    Cognitive impairment in nondemented Parkinson's disease.
    Mov Disord. 2011;26:2483-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. VOLKMANN J
    The Wilson films - Parkinson's disease.
    Mov Disord. 2011;26:2475-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. BARTON B , Grabli D, Bernard B, Czernecki V, et al
    Clinical validation of movement disorder society-recommended diagnostic criteria for Parkinson's disease with dementia.
    Mov Disord. 2011 Dec 9. doi: 10.1002/mds.24059.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. BURN DJ , Landau S, Hindle JV, Samuel M, et al
    Parkinson's disease motor subtypes and mood.
    Mov Disord. 2011 Dec 11. doi: 10.1002/mds.24041.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. OKUN MS
    Parkinson's disease patients cannot get their dopamine replacement: The 8-sinemet limit.
    Mov Disord. 2011 Dec 9. doi: 10.1002/mds.24038.
    PubMed     Text format     Related articles   
    
    
    
30. KIM JS , Cho JW, Shin H, Lee WY, et al
    A Korean Parkinson's disease family with the LRRK2 p.Tyr1699Cys mutation showing clinical heterogeneity.
    Mov Disord. 2011 Dec 9. doi: 10.1002/mds.24033.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. PERON J , Dondaine T, Le Jeune F, Grandjean D, et al
    Emotional processing in Parkinson's disease: A systematic review.
    Mov Disord. 2011 Dec 9. doi: 10.1002/mds.24025.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. NOYCE AJ , Silveira-Moriyama L, Gilpin P, Ling H, et al
    Severe dysphagia as a presentation of Parkinson's disease.
    Mov Disord. 2011 Dec 9. doi: 10.1002/mds.24006.
    PubMed     Text format     Related articles   
    
    
    
33. LEES A , Fahn S, Eggert KM, Jankovic J, et al
    Perampanel, an AMPA antagonist, Found to have no benefit in reducing "Off" time in Parkinson's disease.
    Mov Disord. 2011 Dec 9. doi: 10.1002/mds.23983.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. SAUNDERS-PULLMAN R , Cabassa J, San Luciano M, Stanley K, et al
    LRRK2 G2019S mutations may be increased in Puerto Ricans.
    Mov Disord. 2011;26:1772-3.
    PubMed     Text format     Related articles   
    
    
    

    
    Neurosci Lett

35. SAN LUCIANO M , Ozelius L, Lipton RB, Raymond D, et al
    Gender differences in the IL6 -174G>C and ESR2 1730G>A polymorphisms and the risk of Parkinson's disease.
    Neurosci Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. NOELKER C , Schwake M, Balzer-Geldsetzer M, Bacher M, et al
    Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson's disease.
    Neurosci Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Neuroscience

37. KIM YH , Lussier S, Rane A, Choi SW, et al
    Inducible dopaminergic glutathione depletion in an alpha-synuclein transgenic mouse model results in age-related olfactory dysfunction.
    Neuroscience. 2011;172:379-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Boehringer Ingelheim.

Amedeo is a Flying Publisher website.    Design: